What is Noveome Biotherapeutics worth?
$200.0Mlast known valuation
Noveome Biotherapeutics last raised $36.2M in its Early Stage VC (Aug 2023).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Noveome Biotherapeutics
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2023 | Early Stage VC | $36.2M | ▮ | ▮ |
| Sep 2020 | Seed Round | $870K | ▮ | ▮ |
| Jan 2018 | Early Stage VC | $15.0M | ▮ | ▮ |
| Dec 2015 | Seed Round | $2.2M | ▮ | ▮ |
How Noveome Biotherapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Noveome Biotherapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Noveome Biotherapeutics worth?
- Noveome Biotherapeutics's last known valuation is $200.0M.
- How much has Noveome Biotherapeutics raised?
- Noveome Biotherapeutics has raised $78.7M in total funding across 4 recorded rounds.
- When did Noveome Biotherapeutics last raise?
- Noveome Biotherapeutics last raised in Aug 2023 (Early Stage VC), raising $36.2M.